Aleph Neuro’s post argues that transcranial ultrasound can image brain vasculature at unusually high detail by injecting sulfur hexafluoride microbubbles, tracking them over time, and stacking those detections into a super-resolved map. The article frames that as a step toward cheap wearable brain interfaces and eventually “contrast-free” imaging that would infer blood flow from native signals like red blood cells. People were impressed that ultrasound can get anything useful through the skull at all, and several pointed out that contrast-enhanced ultrasound with microbubbles is already an established clinical technique in other organs. That kept the conversation from dismissing the work outright.
The confidence stopped there. The main pushback was that the demo solves a much narrower problem than the marketing suggests. What is shown is neurovascular imaging built from sparse, injected contrast points and accumulated over time. That is a very different claim from real-time brain decoding, and commenters kept returning to the fact that hemodynamics are already an indirect, slow proxy for neural activity even before you add skull distortion and reconstruction tricks. Several people also wanted the obvious validation step that the post does not show: compare the resulting images directly with
MRI or other established modalities and quantify where ultrasound is better, worse, or simply cheaper.
The strongest technical criticism targeted the leap from microbubbles to “natural contrast.” The current
super-resolution approach works because the bubbles are sparse and acoustically loud, which makes it possible to localize them one by one and combine millions of detections into a finer map. Red blood cells are dense, weak scatterers that fill the vessels continuously, so the signal geometry changes completely. Commenters argued that this turns a tractable localization problem into a much harder reconstruction problem, and that the post hand-waves that gap by gesturing at AI rather than explaining a plausible path. That made the top animation read less like a live image and more like an accumulated composite.
Safety was the other recurring concern. Some commenters noted that brain ultrasound is not obviously benign just because routine diagnostic ultrasound is common elsewhere in the body. Others linked older and review literature claiming possible neural or myelination effects from diagnostic-level exposure, and pointed out that focused ultrasound plus microbubbles is already used in contexts like opening the
blood-brain barrier. Nobody showed that this setup is unsafe, but the bar people wanted was long-term repeat-use data, not general reassurance that ultrasound and sulfur hexafluoride are individually familiar.
On practical use, the most credible near-term case was not consumer telepathy but cheaper, more available neurovascular imaging. People argued this could matter in places where MRI access is slow or scarce, though that sparked a side debate over whether MRI’s limits are technical, economic, or policy-driven. Even there, clinicians pushed back on the idea that a microbubble-based brain vascular scan belongs in small clinics, since acute brain findings still need escalation to major centers. The mood landed in a clear place: promising imaging demo, plausible medical niche, wildly overstated
BCI framing.